Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...
Month: May 2024
T-Mobile to Acquire UScellular Wireless Operations and Deliver Exceptional Value, a Superior 5G Experience and Unparalleled Benefits to Millions of Customers
Un-carrier Will Give UScellular and T-Mobile Customers More Value and Better Experiences, and Spur Growth and Competition that Offers More...
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations...
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
Phase 3 program enrolled 1,984 patients across COAST and ShORe trialsTrials designed to replicate superiority in visual outcomes demonstrated in...
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director Nominees on the BLUE Proxy Card
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN) (“Medallion” or the “Company”) today announced that...
ITURAN LOCATION AND CONTROL LTD ANNOUNCES DISTRIBUTION OF A $8 MILLION DIVIDEND
AZOUR, Israel, May 28, 2024 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN) announced that the Board of Directors approved...
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian...
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative...
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for...
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired an...
24/7 Market News- Kraig Biocraft Laboratories Shares Update on Dragon Silk Production Utilizing the BAM-1 Platform
ANN ARBOR, Mich., – May 28, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("the Company" or "Kraig Labs") announces an update...
Hain Celestial Names Chris Jenkins as Global Head of Impact
Appointment Reinforces Hain's Commitment to Advance its Global Impact Strategy & Build Purpose-Driven Brands that Have a Positive Impact on...
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)
Reference is made to the first quarter 2024 report released on May 28, 2024. Golar LNG Limited (“Golar”), NASDAQ ticker:...
Electrovaya to Present at Craig Hallum and Roth Capital Investor Conferences
TORONTO, ON / ACCESSWIRE / May 28, 2024 / Electrovaya Inc. ("Electrovaya" or the "Company") (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery...
Creative Realities Closes on New Revolving Credit Facility
LOUISVILLE, Ky., May 28, 2024 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a...
BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference
NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence...
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
- Steady growth in APHEXDA® adoption in first full quarter post-approval - - Among top 80 transplant centers, secured APHEXDA formulary placement to...
Alarm.com Announces Proposed Private Placement of $375.0 Million of Convertible Senior Notes
Contacts Investor & Media Relations: Matthew Zartman Alarm.com ir@alarm.com Alarm.com Holdings, Inc. (Nasdaq: ALRM) (“Alarm.com”), the leading platform for the...
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
– Top-line Phase 1 CSU results expected at year end 2024 –SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) --...
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
– Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and...
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024Lausanne, Switzerland, May 28, 2023 – AC Immune...
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
– Results from Preclinical Model of Hyperphosphatemia Demonstrate the Relative Potency of OLC Compared to Tenapanor –– Oral UNI-494 Shows...
Treace to Present at Truist Securities MedTech Conference
PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a...
Siyata Mobile SD7 PTT Handsets Selected by Public Utility to Replace Two-Way Radios
City of Lancaster, Ohio Integrates Solution into Day-to-Day Utility Operations VANCOUVER, BC, May 28, 2024 /PRNewswire/ -- Siyata Mobile Inc. (Nasdaq:...
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PITTSBURGH, May 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today...
Olema Oncology to Participate in Upcoming Investor Conferences in June
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company...
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
MALVERN, Pa., May 28, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted...
Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies
Expands Nordson MEDICAL’s total addressable market Highly complementary with Nordson’s customer base and core competencies Broadens Nordson’s exposure to higher-growth...
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC
67% response rate observed among 24 evaluable patientsConference Call on Tuesday, May 28th at 8 a.m. ETRead more at globenewswire.com
Mobilicom Secures Another Follow-On Order from the U.S. Defense Industry
Production scale order from a U.S. based Tier-1 defense & drone manufacturer for Mobilicom’s solution integration into drone platforms deployed...
Mobilicom Secures Another Follow-On Order from the U.S. Defense Industry
Production scale order from a U.S. based Tier-1 defense & drone manufacturer for Mobilicom’s solution integration into drone platforms deployed...
MindMed to Participate in June Conferences
Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage...
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
Contacts Investors: Jenny Gelinas 312-506-1237 Jenny.Gelinas@veradigm.com Media: Ray Joske ray.joske@veradigm.com Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of...
Laser Photonics and Brokk To Co-Host Table at 2024 RadWaste Summit 2.0
Contacts Investor Relations Contact: laser@haydenir.com Media Contact: Karla Kizzort Marketing Specialist kkizzort@laserphotonics.com Laser Photonics Corporation (NASDAQ: LASE), a leading global...
Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors ---- PAS-004...
Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors ---- PAS-004...
Ionis to hold donidalorsen Phase 3 data webcast
Webcast scheduled for Friday, May 31 at 8:00 a.m. Eastern Time CARLSBAD, Calif., May 28, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc....
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new...
Full Circle Lithium Successfully Tests Its Proprietary Lithium-Ion Battery Fire-Extinguishing Agent with Global EV OEM and the Georgia Ports Authority
TORONTO, May 28, 2024 /PRNewswire/ - Full Circle Lithium Corp. ("FCL" or the "Company") (TSXV: FCLI) (OTCQB: FCLIF), a USA-based...